The effect of magnesium in patients with attention deficit hyperactivity disorder
Phase 3
- Conditions
- Attention deficit hyperactivity disorder.Attention-deficit hyperactivity disorders
- Registration Number
- IRCT20160813029327N19
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
Age between 8-16 years old
Diagnosis of ADHD by the pediatric psychiatrist
Lack of mental retardation
No history of epilepsy and seizure
Intake methylphenidate tablet as the main method of drug therapy
Consent of the patient and parents to participate in the research
Exclusion Criteria
Renal failure
intolerance to magnesium
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Scores in Conner's Parent Rating Scale questionnaire. Timepoint: Before, 4 weeks and 8 weeks after intervention. Method of measurement: Conner's Parent Rating Scale questionnaire.;Scores in ADHD Rating Scale questionnaire. Timepoint: Before, 4 weeks and 8 weeks after intervention. Method of measurement: ADHD Rating Scale questionnaire.
- Secondary Outcome Measures
Name Time Method